Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded on May 22, 1986, and is headquartered in South Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Prescient Therapeutics Limited?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Prescient Therapeutics Limited market cap is $45.22M.
What is the 52-week high for Prescient Therapeutics Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Prescient Therapeutics Limited 52 week high is $0.145 as of October 10, 2025.
What is the 52-week low for Prescient Therapeutics Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Prescient Therapeutics Limited 52 week low is $0.145 as of October 10, 2025.
What is Prescient Therapeutics Limited stock price today?
Prescient Therapeutics Limited stock price today is $0.145.
What was Prescient Therapeutics Limited stock price yesterday?
Prescient Therapeutics Limited stock price yesterday was $0.16.
What is the PE ratio of Prescient Therapeutics Limited?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Prescient Therapeutics Limited’s P/E ratio is -22.31.
What is the Price-to-Book ratio of Prescient Therapeutics Limited?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Prescient Therapeutics Limited P/B ratio is 6.7285.
What is the 50-day moving average of Prescient Therapeutics Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Prescient Therapeutics Limited 50-day moving average is $0.145.
